1. Home
  2. STAA vs MIRM Comparison

STAA vs MIRM Comparison

Compare STAA & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$23.41

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$77.65

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STAA
MIRM
Founded
1982
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
4.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
STAA
MIRM
Price
$23.41
$77.65
Analyst Decision
Hold
Strong Buy
Analyst Count
10
11
Target Price
$24.56
$92.45
AVG Volume (30 Days)
1.5M
844.6K
Earning Date
02-10-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$230,591,000.00
$471,794,000.00
Revenue This Year
N/A
$53.78
Revenue Next Year
$21.97
$19.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.66
52 Week Low
$13.50
$36.88
52 Week High
$30.81
$82.58

Technical Indicators

Market Signals
Indicator
STAA
MIRM
Relative Strength Index (RSI) 43.37 58.25
Support Level $22.97 $77.99
Resistance Level $23.74 $82.58
Average True Range (ATR) 1.11 3.33
MACD -0.08 0.71
Stochastic Oscillator 17.07 74.62

Price Performance

Historical Comparison
STAA
MIRM

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: